13 |
Doxorubicin inhibits PD-L1 expression by enhancing TTP-mediated decay of PD-L1 mRNA in cancer cells
|
관리자 |
작성일21.01.13 |
조회386 |
12 |
Tristetraprolin posttranscriptionally downregulates PFKFB3 in cancer cells
|
관리자 |
작성일21.01.13 |
조회342 |
11 |
Tristetraprolin-mediated hexokinase 2 expression regulation contributes to glycolysis in cancer cells
|
관리자 |
작성일21.01.13 |
조회337 |
10 |
Tristetraprolin inhibits mitochondrial function through suppression of α-Synuclein expression in cancer cells
|
관리자 |
작성일21.01.13 |
조회322 |
9 |
Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells
|
관리자 |
작성일21.01.13 |
조회313 |
8 |
Tristetraprolin down-regulates IL-23 expression in colon cancer cells
|
관리자 |
작성일21.01.13 |
조회332 |
7 |
Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells
|
관리자 |
작성일21.01.13 |
조회346 |
6 |
Tristetraprolin suppresses AHRR expression through mRNA destabilization
|
관리자 |
작성일21.01.13 |
조회359 |
5 |
Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells
|
관리자 |
작성일21.01.13 |
조회385 |
4 |
Ectopic over-expression of tristetraprolin in human cancer cells promotes biogenesis of let-7 by down-regulation of Lin28
|
관리자 |
작성일21.01.13 |
조회394 |